Terms: = Bone cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Clinical Outcome
4 results:
1. NKX2-5, sil/TAL and TLX3/HOX11L2 expression in Egyptian pediatric T-cell acute lymphoblastic leukemia.
Moussa H; Sidhom I
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e1-10. PubMed ID: 24571118
[TBL] [Abstract] [Full Text] [Related]
2. Interleukin-6 in bone metastasis and cancer progression.
Ara T; Declerck YA
Eur J Cancer; 2010 May; 46(7):1223-31. PubMed ID: 20335016
[TBL] [Abstract] [Full Text] [Related]
3. Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma.
Egler RA; Burlingame SM; Nuchtern JG; Russell HV
Clin Cancer Res; 2008 Nov; 14(21):7028-34. PubMed ID: 18980999
[TBL] [Abstract] [Full Text] [Related]
4. Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?
Ferrari L; Bajetta E; Martinetti A; Celio L; Longarini R; La Torre I; Buzzoni R; Gattinoni L; Seregni E; Bombardieri E
Int J Oncol; 2003 May; 22(5):1081-9. PubMed ID: 12684675
[TBL] [Abstract] [Full Text] [Related]
